Washington Post examines HIV, TB epidemics in Russia

The Washington Post examines how the HIV and tuberculosis (TB) epidemics are affecting Russia, where "HIV/AIDS was the third-largest cause of premature death," according to recently released data in the Global Burden of Disease Study 2012 (GBD). "When the study grouped countries by income, Russia was compared to 14 others, including the Baltics, Lebanon, Libya, Mexico and Botswana," the newspaper writes, adding, "On many measures, Botswana did better than Russia, but they were close on premature deaths from HIV/AIDS and tuberculosis and on life expectancy -- 68.9 in Russia in 2010 and 71 in Botswana."

The newspaper details the increasing number of HIV/AIDS and TB cases, including multidrug-resistant cases, in the country; reasons behind the rising numbers; and the historical impact of the fall of the Soviet Union. The Washington Post includes comments from Christopher Murray, director of the Institute for Health Metrics and Evaluation at the University of Washington, which produced the GBD; Anya Sarang, president of the Andrey Rylkov Foundation for Health and Social Justice; Vadim Pokrovsky, head of Russia's Federal AIDS Center; and Olga Nechaeva, head of Russia's federal TB monitoring center (Lally, 3/28).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug